Ojjaara (momelotinib) is the only approved treatment for newly diagnosed and previously treated myelofibrosis patients i who ...

JACKSON, Miss. (WLBT) - On Tuesday, the American Red Cross launched a fight against Sickle Cell Anemia by hosting blood ...

An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...

Roxadustat is approved in China, Europe, Japan, and numerous other countries for the treatment of anemia of CKD in adult patients on dialysis (DD) and not on dialysis (NDD). Astellas and FibroGen are ...

The Wixom, Michigan-based company said it had net income of 5 cents per share. The maker of products used in the treatment of kidney disease and anemia posted revenue of $28.3 million in the period.

This quarterly report represents an earnings surprise of 400%. A quarter ago, it was expected that this maker of products used in the treatment of kidney disease and anemia would post a loss of $0.04 ...

The Humane Society of Louisiana is addressing an increase in animals being dumped in New Orleans East. According to the ...

A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...

Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) today. The ...

The treatment’s overall response rate was 47% in the phase ... including QTc prolongation (21%); anemia (14%); febrile ...

Five Americans caught a sexually transmitted infection every minute last year as cases remained at a near record high. But ...

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.